Research news

18 May 2012
New registry brings hope for families with myotonic dystrophy A new patient registry for individuals with myotonic dystrophy type 1, funded through a partnership between the Muscular Dystrophy Campaign and the Myotonic Dystrophy Support Group, is being launched.

17 January 2012
Highlights from the International Myotonic Dystrophy Consortium meeting A meeting in Florida has brought together more than 200 scientists and clinicians from around the world to discuss the latest research developments in myotonic dystrophy

10 November 2011
Highlights from the World Muscle Society Congress Our Director of Research, Dr Marita Pohlschmidt and Head of Grants, Dr Julia Ambler, attended the World Muscle Society congress and here they summarise their highlights.

25 August 2011
Two research teams make steps towards a treatment for FSH Researchers have successfully used a gene therapy approach to reverse the symptoms of facioscapulohumeral muscular dystrophy in a mouse model, a technique that could also be applied to other muscle conditions.

5 August 2011
New lead for myotonic dystrophy treatment Researchers in Spain recently identified a new way to block the genetic change that causes myotonic dystrophy type 1.

4 July 2011
Next generation of Duchenne exon skipping drugs in the pipeline Research funded by the Muscular Dystrophy Campaign has resulted in the development of the next generation of exon skipping drugs which is on target for testing in a clinical trial in 2013.

6 April 2011
Stem cells give insight into myotonic dystrophy Researchers studying human embryonic stems cells have found two new genes that are affected in myotonic dystrophy.

25 May 2010
Heart drug shows promise for the treatment of myotonic dystrophy symptoms Clinical trials in the US have shown that the heart drug mexiletine is able to help relieve muscle stiffness for people with myotonic dystrophy.

26 January 2010
Researchers identify new mutation in myotonic dystrophy type 1 Research funded by the Muscular Dystrophy Campaign has discovered a new type of mutation that affects the severity and inheritance of myotonic dystrophy type 1.